Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Magdalena Lason-Tyburkiewicz"'
Autor:
Monika Niemczyk, Mariusz Papp, Magdalena Lason-Tyburkiewicz, Piotr Gruca, Ronan Depoortère, Adrian Newman-Tancredi, Mark A. Varney
Publikováno v:
Journal of Psychopharmacology. 33:1456-1466
Background:NLX-101 (also known as F15599) is a highly selective and efficacious ‘biased’ agonist at cortical 5-hydroxytryptamine 1A (5-HT1A) heteroreceptors. In rodents, it possesses marked antidepressant-like activity, potently and completely ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c5b4375e3de13f9f0ae52809e0f91a
https://doi.org/10.1177/0269881119860666
https://doi.org/10.1177/0269881119860666
Autor:
Joanna Solich, Marta Szlachta, Paul Willner, Agata Faron-Górecka, Piotr Gruca, Ewa Litwa, Katarzyna Tota-Glowczyk, Monika Niemczyk, M. Kusmider, Mariusz Papp, Magdalena Lason-Tyburkiewicz
Publikováno v:
Behavioural Pharmacology. 29:537-542
We have previously reported the effects of intracranial injections of dopamine D1, D2 and D3 ligands in animals subjected to the Novel Object Recognition (NOR) test following exposure to chronic mild stress (CMS) and chronic treatment with risperidon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab9d6239e4f0ba0088e144cc80f3a8b
https://doi.org/10.1097/fbp.0000000000000392
https://doi.org/10.1097/fbp.0000000000000392
Autor:
Mariusz Papp, Monika Niemczyk, Ewa Litwa, Piotr Gruca, Paul Willner, Katarzyna Tota-Glowczyk, Magdalena Lason-Tyburkiewicz
Publikováno v:
Psychopharmacology
Cognitive deficits in depression can be modelled using the novel object recognition (NOR) test, performance in which is impaired by chronic mild stress (CMS). We aimed to examine the involvement of mesocorticolimbic DA terminal regions, and to establ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c6aa168b35bb47c9b437c8ccc53259
https://doi.org/10.1007/s00213-017-4651-4
https://doi.org/10.1007/s00213-017-4651-4
Publikováno v:
Behavioural Pharmacology. 28:1-8
Ketamine is the prototype of a new generation of antidepressant drugs, which is reported in clinical studies to be effective in treatment-resistant patients, with an effect that appears within hours and lasts for a few days. Chronic mild stress (CMS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfeebe480cc5be8dfb5904bf73d04814
https://doi.org/10.1097/fbp.0000000000000259
https://doi.org/10.1097/fbp.0000000000000259
Autor:
Andrea C, Rossetti, Maria Serena, Paladini, Martina, Colombo, Piotr, Gruca, Magdalena, Lason-Tyburkiewicz, Katarzyna, Tota-Glowczyk, Mariusz, Papp, Marco A, Riva, Raffaella, Molteni
Publikováno v:
International Journal of Neuropsychopharmacology
Background Psychiatric disorders are associated with altered function of inhibitory neurotransmission within the limbic system, which may be due to the vulnerability of selective neuronal subtypes to challenging environmental conditions, such as stre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0dfb8b52ad5d22d038b731e7a613d654
https://pubmed.ncbi.nlm.nih.gov/29788232
https://pubmed.ncbi.nlm.nih.gov/29788232
Autor:
Paul Willner, Magdalena Lason-Tyburkiewicz, M. Niemczyk, Mariusz Papp, K. Tota-Glowczyk, Ewa Litwa, Piotr Gruca
Publikováno v:
European Neuropsychopharmacology. 29:S558-S559
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbc642d6adb83ac57518f422f3ae9969
https://doi.org/10.1016/j.euroneuro.2018.11.830
https://doi.org/10.1016/j.euroneuro.2018.11.830
Autor:
Marco A. Riva, Francesca Calabrese, Magdalena Lason-Tyburkiewicz, Paola Brivio, Piotr Gruca, Mariusz Papp
Publikováno v:
ACS chemical neuroscience. 8(4)
Depression, a major cause of disability worldwide, is characterized by a complex and heterogeneous symptomatology. With this respect, cognitive deterioration represents a major problem that has a strong impact on a patient's function. Thus, within th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614af328a3ff4f7b7abeb1e1daaa7691
https://pubmed.ncbi.nlm.nih.gov/28094500
https://pubmed.ncbi.nlm.nih.gov/28094500
Publikováno v:
Psychopharmacology
Background The treatment of depression in old age is complicated by frequent co-morbidity with cognitive impairment. Anti-dementia drugs have some efficacy to improve cognitive performance and there is an inconsistent literature regarding the effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266203726a8c2ab405deba7add24ff22
https://pubmed.ncbi.nlm.nih.gov/26769042
https://pubmed.ncbi.nlm.nih.gov/26769042
Autor:
Piotr Gruca, Marcin Marciniak, Andrzej Pilc, Joanna M. Wierońska, Mariusz Papp, Magdalena Lason-Tyburkiewicz, Francine Acher, Monika Woźniak
Publikováno v:
Current Neuropharmacology
Considering that ligands of metabotropic glutamate and GABA receptors may exert beneficial effects on schizophrenia, we assessed the actions of the first mGlu>4-selective orthosteric agonist, LSP4-2022, in several tests reflecting positive, negative,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af88f8ba6d184ee9ec425289cc930e3e
https://pubmed.ncbi.nlm.nih.gov/26769224
https://pubmed.ncbi.nlm.nih.gov/26769224
Autor:
K. Tota-Glowczyk, Paul Willner, Piotr Gruca, Magdalena Lason-Tyburkiewicz, M. Niemczyk, Mariusz Papp, Ewa Litwa
Publikováno v:
European Neuropsychopharmacology. 27:S770
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::719d15c47ce88a616ee67b19f9d38aeb
https://doi.org/10.1016/s0924-977x(17)31406-2
https://doi.org/10.1016/s0924-977x(17)31406-2